Bell S - Search Results

1

Long-term outcomes of perianal fistulizing Crohn's disease in the biologic era.

Lee T, Kamm MA, Bell S, Lust M, Brown S, Niewiadomski O, Basnayake C, Wright E, D'Souza B, Woods R, Wei SC, Connell W, Thompson A, Yong E, Ding NS. Lee T, et al. Among authors: bell s. JGH Open. 2020 Dec 20;5(2):235-241. doi: 10.1002/jgh3.12475. eCollection 2021 Feb. JGH Open. 2020. PMID: 33553661 Free PMC article.

2

Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.

Bell S, Kamm MA. Bell S, et al. Lancet. 2000 Mar 11;355(9207):858-60. doi: 10.1016/S0140-6736(99)00442-0. Lancet. 2000. PMID: 10752696 No abstract available.

3

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.

Bell SJ, Kamm MA. Bell SJ, et al. Aliment Pharmacol Ther. 2000 May;14(5):501-14. doi: 10.1046/j.1365-2036.2000.00777.x. Aliment Pharmacol Ther. 2000. PMID: 10792111 Review.

4

Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging.

Bell SJ, Halligan S, Windsor AC, Williams AB, Wiesel P, Kamm MA. Bell SJ, et al. Aliment Pharmacol Ther. 2003 Feb;17(3):387-93. doi: 10.1046/j.1365-2036.2003.01427.x. Aliment Pharmacol Ther. 2003. PMID: 12562451

5

The clinical course of fistulating Crohn's disease.

Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RC, Kamm MA. Bell SJ, et al. Aliment Pharmacol Ther. 2003 May 1;17(9):1145-51. doi: 10.1046/j.1365-2036.2003.01561.x. Aliment Pharmacol Ther. 2003. PMID: 12752351

6

Evaluation of Helicobacter species in inflammatory bowel disease.

Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA. Bell SJ, et al. Aliment Pharmacol Ther. 2003 Sep 1;18(5):481-6. doi: 10.1046/j.1365-2036.2003.01703.x. Aliment Pharmacol Ther. 2003. PMID: 12950420

7

Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice.

Brown SJ, Miller AM, Cowan PJ, Slavin J, Connell WR, Moore GT, Bell S, Elliott PR, Desmond PV, d'Apice AJ. Brown SJ, et al. Among authors: bell s. Inflamm Bowel Dis. 2004 Sep;10(5):546-56. doi: 10.1097/00054725-200409000-00008. Inflamm Bowel Dis. 2004. PMID: 15472514

8

Characteristics of intestinal dendritic cells in inflammatory bowel diseases.

Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, Kamm MA, Stagg AJ. Hart AL, et al. Gastroenterology. 2005 Jul;129(1):50-65. doi: 10.1053/j.gastro.2005.05.013. Gastroenterology. 2005. PMID: 16012934

9

Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors.

Thompson AJ, Ayres A, Yuen L, Bartholomeusz A, Bowden DS, Iser DM, Chen RY, Demediuk B, Shaw G, Bell SJ, Watson KJ, Locarnini SA, Desmond PV. Thompson AJ, et al. J Gastroenterol Hepatol. 2007 Jul;22(7):1078-85. doi: 10.1111/j.1440-1746.2006.04630.x. J Gastroenterol Hepatol. 2007. PMID: 17608854

10

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.

Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA. Nguyen T, et al. Among authors: bell s. J Hepatol. 2010 Apr;52(4):508-13. doi: 10.1016/j.jhep.2010.01.007. Epub 2010 Feb 16. J Hepatol. 2010. PMID: 20206400 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,821 results

Search Page

Filters